PBE 股价预测及 ETF 分析 - 分红·管理费·持仓·NAV·RSI·MACD

Q: PBE是否支付分红（分配）？

PBE的分红收益率约为 1.34%。

PBE

Invesco Biotechnology & Genome ETF

收盘价 10月27日 3:49 PM ET（韩国 10/28 04:49）

$99.21

+0.49 ▲ +0.50%

上升通道阻力线 103.13 支撑线 94.56 维持由 AI 绘制的参考线，可能有误，仅供参考，并非预测。

详细指标表

Category ⓘ	US Equities - Industry Sector	Expense ⓘ	0.59%	Return% 1Y ⓘ	37.83%	Total Holdings ⓘ	31	Perf Week ⓘ	2.59%	Volume ⓘ	20,138
Asset Type ⓘ	Equities (Stocks)	AUM ⓘ	$429M	Return% 3Y ⓘ	21.45%	NAV ⓘ	$98.63	Perf Month ⓘ	2%	Avg Volume ⓘ	0.03M
ETF Type ⓘ	US Equities	Dividend TTM ⓘ	$1.33 (1.34%)	Return% 5Y ⓘ	6.28%	52W High ⓘ	-0.78%	Perf Quarter ⓘ	8.14%	Rel Volume ⓘ	0.69
Active/Passive ⓘ	Passive	Div Gr. 3/5Y ⓘ	- 95.02%	Return% 10Y ⓘ	9.96%	52W Low ⓘ	37.27%	Perf Half Y ⓘ	24.11%	Prev Close ⓘ	$98.72
IPO ⓘ	2005/6/23	Flows% 1M ⓘ	-0.22%	Return% SI ⓘ	9.6%	RSI (14) ⓘ	57.91	Perf YTD ⓘ	20.76%	Price ⓘ	$99.21
Beta ⓘ	0.72	Flows% 3M ⓘ	34.7%	Flows% YTD ⓘ	34.83%	Flows% 1Y ⓘ	35.91%	Perf Year ⓘ	35.11%	Volatility(W/M) ⓘ	1.41% 1.68%
SMA20 ⓘ	2.38%	SMA50 ⓘ	2.79%	SMA200 ⓘ	14.23%	ATR ⓘ	1.73

ETF 简介

Invesco Biotechnology & Genome ETFPBE | NYSE | 一般ETF 查看深度分析

Invesco Dynamic Biotechnology & Genome ETF seeks to track the investment results (before fees and expenses) of the Dynamic Biotech & Genome IntellidexSM Index. The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.

PBE ETF 一览

0.59% 越低越好

$429M 管理资产

31只

1.34% 季度分红

上市日期 2005年

运作方式跟踪指数

管理公司 Invesco

主要持仓持有31只

前10大持仓占 基金的57%